0001493152-24-011793.txt : 20240328 0001493152-24-011793.hdr.sgml : 20240328 20240328171610 ACCESSION NUMBER: 0001493152-24-011793 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240321 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Changes in Control of Registrant ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edoc Acquisition Corp. CENTRAL INDEX KEY: 0001824884 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39689 FILM NUMBER: 24800402 BUSINESS ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 BUSINESS PHONE: 5856781198 MAIL ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 8-K 1 form8-k.htm
false --12-31 0001824884 0001824884 2024-03-21 2024-03-21 0001824884 ADOC:ClassOrdinaryShares.0001ParValuePerShareMember 2024-03-21 2024-03-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): March 21, 2024

 

EDOC Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-39689   N/A
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

7612 Main Street Fishers

Suite 200

Victor, NY 14564

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (585) 678-1198

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   N/A   N/A

 

 

 

 
 

 

Introductory Note

 

On March 21, 2024, Edoc Acquisition Corp. (the “Company” or “EDOC”) and Australian Oilseeds Investments Pty Ltd., an Australian proprietary company (the “AOI”), completed their previously announced business combination pursuant to the terms of the Business Combination Agreement, dated as of December 5, 2022 (as amended on March 31, 2023 and December 7, 2023, the “Business Combination Agreement”), by and among the Company, AOI, Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (“Pubco”), AOI Merger Sub, Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“Merger Sub”), American Physicians LLC, a Delaware limited liability company (the “Sponsor”), in the capacity as the Purchaser Representative thereunder, and Gary Seaton, in his capacity as the representative for the Sellers (as defined in the Business Combination Agreement) in accordance with the terms and conditions of the Business Combination Agreement (the “Seller Representative”) and each of the holders of AOI’s outstanding ordinary shares named on Annex I to the Business Combination Agreement (the “Primary Sellers”), as amended from time to time, to include subsequent parties that execute and deliver to Purchaser, Pubco and AOI, a Joinder (the “Joining Sellers”), and the holders of AOI’s outstanding ordinary shares who are bound by the provisions of the Business Combination Agreement pursuant to the drag-along rights set forth in AOI’s memorandum and articles of association (the “Drag-Along Sellers,” and collectively with the Joining Sellers, the “Sellers”).”), which, among other things provided for the merger of EDOC with and into Merger Sub (the “Merger”).

 

In connection with the consummation of the transactions contemplated by the Business Combination Agreement (the “Business Combination”), each of AOI and the Company became a direct wholly-owned subsidiary of Pubco.

 

In connection with the Closing of the Business Combination, Pubco’s ordinary shares and warrants began trading on The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbols “COOT” and “COOTW,” respectively, on March 22, 2024.

 

Item 1.01. Entry into a Material Definitive Agreement.

 

The information set forth the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference in its entirety. In connection with the consummation of Business Combination, the parties to the Business Combination entered into the following agreements:

 

Lock-Up Waiver

 

Simultaneously with the closing of the Business Combination (the “Closing”), the Company, certain persons and entities holding EDOC’s founder shares and private placement units (each, a “Lock-Up Party”), entered into a lock-up waivers so as to permit the following: (A) the distribution by the Sponsor of all of its Company securities (the “Sponsor Distribution”), including (i) an aggregate of 1,485,153 Insider Shares (as defined in the Letter Agreement, dated November 9, 2020, by and among EDOC, the Sponsor and the directors and officers of EDOC named therein, as amended by that certain First Amendment to Letter Agreement, dated December 5, 2022 (the “Letter Agreement”)), and (ii) an aggregate of 414,000 Insider Units (as defined in the unit subscription agreements, dated November 9, 2020, by and between EDOC and the other parties thereto, including the Sponsor and I-Bankers Securities Inc. (the “Subscription Agreements”)), including their underlying securities; (B) of the securities distributed in the Sponsor Distribution, an aggregate of 809,902 shares held by recipients who are not affiliates of Pubco shall be released of all post-Closing lock-up restrictions pursuant to the Letter Agreement or the Subscription Agreements; and (C) an aggregate of 65,000 Insider Units held by I-Bankers Securities Inc., including their underlying securities, shall be released of all post-Closing lock-up restrictions pursuant to the Subscription Agreements. The remaining securities distributed pursuant to the Sponsor Distribution will continue to be subject to the lock-up restrictions of the Letter Agreement and the Subscription Agreements following such transfer.

 

 
 

 

Agreements Related to Transaction Expenses

 

In connection with the Closing, EDOC and Pubco entered into certain arrangements to repay certain Business Combination transaction expenses incurred by EDOC and otherwise due at Closing. These arrangements include fee modification agreements with vendors pursuant to which such vendors will receive deferred cash payments of approximately $4.6 million.

 

Item 2.01. Completion of Acquisition or Disposition of Assets.

 

On March 21, 2024, pursuant to the Business Combination Agreement, the following transactions occurred at the effective time of the Merger (the “Effective Time”):

 

EDOC merged with and into Merger Sub, with EDOC continuing as the surviving entity, as a result of which:

 

(i) EDOC became a wholly-owned subsidiary of Pubco, and

 

(ii) each issued and outstanding security of EDOC immediately prior to the Effective Time was automatically be cancelled, in exchange for the right of the holder thereof to receive substantially identical securities of Pubco, and

 

Pubco acquired all of the issued and outstanding ordinary shares of AOI (the “Purchased Shares”) from the Sellers in exchange for ordinary shares of Pubco, par value $0.0001 per share (“Pubco Ordinary Shares”)

 

As previously disclosed, in connection with the extraordinary general meeting of EDOC shareholders, which extraordinary general meeting was held on March 5, 2024 (the “Special Meeting”), the public shareholders of EDOC had the right to elect to redeem all or a portion of their ordinary shares of EDOC (“Public Shares”) for a pro rata portion of the trust account holding the proceeds from EDOC’s initial public offering, calculated on the date of the Special Meeting. 650,039 Public Shares were redeemed in connection with the Special Meeting for the Business Combination.

 

The ordinary shares and warrants of Pubco commenced trading on The NASDAQ Stock Market LLC under the ticker symbol “COOT” and “COOTW,” respectively on March 22, 2024.

 

The foregoing description of the Business Combination Agreement is qualified in its entirety by reference to the full text of the Business Combination Agreement and the amendments thereto, which are included as Exhibits 2.1, 2.2 and 2.3 to this Current Report, respectively, and are incorporated herein by reference.

 

Immediately following the consummation of the Business Combination, on March 21, 2024, the issued share capital of Pubco consisted of 23,224,102 ordinary shares and 9,629,000 warrants.

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Material Modification to Rights of Security Holders.

 

The information set forth the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference in its entirety.

 

On March 21, 2024, in connection with the consummation of the Business Combination, EDOC notified Nasdaq that the Business Combination had become effective and requested that Nasdaq file a Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on Form 25 (the “Form 25”) to notify the SEC that EDOC’s ordinary shares, warrants and rights were to be delisted and deregistered under Section 12(b) of the Exchange Act. As a result of the Business Combination having become effective, Nasdaq determined to permanently suspend trading of EDOC’s ordinary shares, warrants and rights prior to the opening of trading on March 22, 2024. The deregistration will become effective 10 days from the filing of the Form 25, which occurred on March 22, 2024. EDOC intends to file a Form 15 with the SEC in order to complete the deregistration of NCAC’s securities under the Exchange Act.

 

 
 

 

Item 3.02. Unregistered Sales of Equity Securities.

 

In connection with the Closing, the Sponsor, EDOC and Pubco entered into an arrangement (the “Note Restructuring”) regarding existing promissory notes previously issued to the Sponsor (which notes were previously disclosed by EDOC on its Current Reports on Form 8-K). Pursuant to the Note Restructuring, the following transactions were completed:

 

The promissory note issued by EDOC to the Sponsor, dated November 10, 2021 (the “November 2021 Note”) for an aggregate principal amount of $900,000 was converted into 90,000 private placement units issued by EDOC (which were subsequently exchanged for securities of Pubco upon the Closing) and the Sponsor forgave any unpaid interest that may have accrued on the November 2021 Note through the date of the Closing;
$600,000 of the aggregate principal amount of $750,000 of the the promissory note issued by EDOC to the Sponsor, dated February 13, 2022 was converted into 60,000 private placement units issued by EDOC (which were subsequently exchanged for securities of Pubco upon the Closing);
The following promissory notes were forgiven by the Sponsor and cancelled by EDOC:

 

(i)a promissory note issued by EDOC to the Sponsor, dated August 25, 2022, in the aggregate principal amount of $202,460;
(ii)a promissory note issued by the EDOC to the Sponsor, dated October 6, 2022, in the aggregate principal amount of $500,000;
(iii)a promissory note issued by EDOC to the Sponsor, dated November 16, 2022, in the aggregate principal amount of $303,994;
(iv)a promissory note issued by EDOC to the Sponsor, dated January 10, 2023, in the aggregate principal amount of $256,313
(v)a promissory note issued by EDOC to the Sponsor, dated February 14, 2023, in the aggregate principal amount of $450,000;
(vi)a promissory note issued by EDOC to the Sponsor, dated April 25, 2023, in the aggregate principal amount of $175,000;
(vii)a promissory note issued by EDOC to the Sponsor, dated June 26, 2023, in the aggregate principal amount of$250,000;
(viii)a promissory note issued by EDOC to the Sponsor, dated August 15, 2023, in the aggregate principal amount of $124,932;
(ix)a promissory note issued by the EDOC to the Sponsor, dated November 8, 2023, in the aggregate principal amount of $122,431;
(x)a promissory note issued by EDOC to the Sponsor, dated November 28, 2023, in the aggregate principal amount of $250,000;
(xi)a promissory note issued by EDOC to the Sponsor, dated February 12, 2024, in the aggregate principal amount of $250,000.

 

Upon the Closing, Pubco issued two promissory notes to the Sponsor, one for an aggregate amount of $450,000 and one for an aggregate amount of $500,000.

 

 
 

 

Item 3.03. Material Modifications to Rights of Security Holders.

 

To the extent required by Item 3.03 of Form 8-K, the disclosure set forth in Items 1.01 and 2.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.03.

 

Item 5.01. Changes in Control of Registrant.

 

The information set forth the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference in its entirety. To the extent required by Item 5.01 of Form 8-K, the disclosure set forth in Item 2.01 of this Current Report on Form 8-K is incorporated by reference in this Item 5.01.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The information set forth the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference in its entirety. To the extent required by Item 5.02 of Form 8-K, the disclosure set forth in Item 5.01 of this Current Report on Form 8-K is incorporated by reference in this Item 5.02.

 

In connection with the consummation of the Business Combination, each of Kevin Chen, Bob Ai, Gang Li, Yan Michael Li and Zintao Zheng ceased to be director and/or officers of EDOC.

 

Following the consummation of the Business Combination, Menaka Athukorala, Kevin Chen, Kapil Singh, Gowri Shankar and Gary Seaton were appointed to serve as directors of Pubco, and the board of directors of Pubco appointed the following officers: Gary Seaton as Chief Executive Officer and Chairman and Bob Wu as Chief Financial Officer.

 

Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

 

The information set forth the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference in its entirety.

 

In connection with the consummation of the Business Combination, at the Effective Time of the Business Combination, EDOC adopted an amended and restated memorandum and articles of association which are substantially in the form as described in the Proxy Statement, in accordance with EDOC becoming a wholly-owned subsidiary of Pubco in connection with the Merger.

 

Item 8.01 Other Events

 

On March 21, 2024, the parties issued a press release announcing the completion of the Business Combination, a copy of which is furnished as Exhibit 99.1 hereto.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
2.1   Business Combination Agreement, dated as of December 5, 2022, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited, upon execution of a joinder agreement to become party thereto, AOI Merger Sub, upon execution of a joinder to become party thereto, Australian Oilseeds Investments Pty Ltd., Gary Seaton, in the capacity thereunder as the Seller Representative, and the shareholders of AOI named as Sellers therein (incorporated by reference to Exhibit 2.1 of EDOC’s Form 8-K filed with the SEC on December 9, 2022).
2.2   Amendment No. 1 to Business Combination Agreement, dated as of March 31, 2023, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited and AOI Merger Sub (incorporated by reference to Exhibit 2.1 of EDOC’s Form 8-K filed with the SEC on April 6, 2023).
2.3   Amendment No. 2 to Business Combination Agreement, dated as of March 31, 2023, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited and AOI Merger Sub (incorporated by reference to Exhibit 2.1 of EDOC’s Form 8-K filed with the SEC on December 7, 2023).
10.1   Lock-Up Waiver, dated March 21, 2024, by and among EDOC, Pubco and the other parties thereto
99.1   Press Release, dated March 21, 2024
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: March 28, 2024 EDOC Acquisition Corp.
     
  By: /s/ Gary Seaton
  Name:

Gary Seaton

  Title: Chief Executive Officer

 

 

 

EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

I-Bankers Securities, Inc.

535 5th Ave

Suite 423

New York, New York 10017

Attn.: Mike McCrory, Chief Executive Officer

 

March 21, 2024

 

Ladies and Gentlemen:

 

Reference is made to the letter agreement, dated November 9, 2020, by and among, Edoc Acquisition Corp., a Cayman Islands exempted company (the “Company”), American Physicians LLC, a Delaware limited liability company (the “Sponsor”), and the directors, officers of the Company named therein (collectively with the Representative, the “Lock-Up Parties”), as amended by that certain First Amendment to Letter Agreement, dated December 5, 2022 (as amended, the “Letter Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Letter Agreement.

 

Reference is also made to the underwriting agreement, dated November 9, 2020 (the “Underwriting Agreement”), by and between the Company and I-Bankers Securities Inc., as Representative (the “Representative”) of the several Underwriters named in Schedule A thereto, relating to an underwritten initial public offering of the Company’s units.

 

Reference is further made to that certain Business Combination Agreement, dated as of December 5, 2022 (as amended on March 31, 2023 and December 7, 2023, and as may be further amended, the “Business Combination Agreement”, and all of the transactions contemplated thereunder, the “Business Combination”), by and among the Company, the Sponsor, in the capacity as the representative from and after the closing of the transactions contemplated by the Business Combination Agreement for the shareholders of Purchaser and Pubco (other than the Sellers) in accordance with the terms and conditions of the Business Combination Agreement (the “Purchaser Representative”), Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (“Pubco”), Australian Oilseeds Investments Pty Ltd. (“AOI”), an Australian proprietary company (“AOI”), AOI Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“Merger Sub”), Gary Seaton, in his capacity as the representative for the Sellers in accordance with the terms and conditions of the Business Combination Agreement (the “Seller Representative”) and the other parties thereto.

 

Reference is further made to (i) that certain unit subscription agreement, dated as of November 9, 2020, by and among the Company and the Sponsor and (ii) that certain unit subscription agreement, dated as of November 9, 2020, by and among the Company and the Representative (each, a “Subscription Agreement”).

 

As you are aware, pursuant to Section 3(a) of the Letter Agreement, the Initial Shareholders agreed not to Transfer any Insider Shares: (x) with respect to 50% of its Insider Shares, until the earlier of (i) six (6) months after the date of the consummation of the Business Combination or (ii) the date on which the closing price of the Ordinary Shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Business Combination; and (y) with respect to the remaining 50% of their Insider Shares, six (6) months after the date of the consummation of the Business Combination, or earlier, in either case, if, subsequent to the Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property.

 

 

 

 

Additionally, pursuant to Section 3(b) of the Letter Agreement and Section 5 of the respective Subscription Agreements, the Sponsor, the Representative and each Insider agreed not to effectuate any Transfer of securities issued or issuable upon the exercise of the Private Units or their underlying securities until 30 days after the completion of the Business Combination.

 

In connection with and in furtherance of the Business Combination, the Lock-up Parties hereby request that each of the undersigned waive compliance by the applicable Lock-up Parties with Sections 3(a) and 3(b) of the Letter Agreement and Section 5 of the respective Subscription Agreement, as applicable, as follows:

 

Immediately prior to the consummation of the Business Combination, Sponsor shall distribute all of its securities, including an aggregate of (i) 1,485,153 Insider Shares, (ii) securities underlying 414,000 Private Units (collectively, the “Distribution Securities”), to its constituent members (such transaction, the “Sponsor Distribution”). Sponsor shall be released from all of its obligations pursuant to Sections 3(a) and 3(b) of the Letter Agreement and Section 5 of its Subscription Agreement with respect to the Sponsor Distribution, except that those recipients of the Distribution Securities in the names and amounts set forth on Annex I hereto shall assume, and continue to be subject to, the obligations set forth in Sections 3(a) and 3(b) of the Letter Agreement and Section 5 of its Subscription Agreement upon receipt thereof.
Representative shall be released from its obligations pursuant to Section 5 of its Subscription Agreement with respect to its Private Units.

 

By signing the counterpart to this letter, each of the undersigned, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, hereby waives the compliance by the Lock-up Parties with Sections 3(a) and 3(b) of the Letter Agreement and Section 5 of the respective Subscription Agreement, as applicable. Except as specifically waived herein, the parties to the Letter Agreement retain all rights, and each Lock-up Party retains all obligations, as set forth in the Letter Agreement, and the Subscription Agreements and the Representative retains all rights as set forth in the Underwriting Agreement.

 

[Signature page follows]

 

 

 

 

 

  If you are in agreement with the foregoing, kindly indicate such agreement by signing the counterpart to this letter and returning the signed copy thereof to the Company at the address first written above or by e-mail at [ ].
   
  Sincerely,
   
  American Physicians LLC
   
  /s/ Xiaoping Becky Zhang
  Name:

Xiaoping Becky Zhang

  Title: Managing Member
     
  I-Bankers Securities, Inc.
     
  /s/ Matthew McCloskey
  Name: Matthew McCloskey
  Title: Head of Equity Capital Markets

 

ACKNOWLEDGED AND AGREED TO THIS 21st DAY OF March 2024:
 
I-Bankers Securities Inc.
     
/s/ Matthew McCloskey  
Name: Matthew McCloskey  
Title:

Managing Director

 
     
EDOC Acquisition Corp.
     
/s/ Kevin Chen  
Name: Kevin Chen  
Title: Chief Executive Officer  
     
Australian Oilseeds Holdings Limited
 
/s/ Gary Seaton  
Name: Gary Seaton  
Title: Chief Executive Officer  

 

[Signature Page to Lockup Waiver Letter]

 

 

EX-101.SCH 3 adoc-20240321.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 adoc-20240321_def.xml XBRL DEFINITION FILE EX-101.LAB 5 adoc-20240321_lab.xml XBRL LABEL FILE Class of Stock [Axis] Class A Ordinary Shares, $.0001 par value per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 adoc-20240321_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 21, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 21, 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-39689
Entity Registrant Name EDOC Acquisition Corp.
Entity Central Index Key 0001824884
Entity Incorporation, State or Country Code E9
Entity Address, Address Line One 7612 Main Street Fishers
Entity Address, Address Line Two Suite 200
Entity Address, City or Town Victor
Entity Address, State or Province NY
Entity Address, Postal Zip Code 14564
City Area Code (585)
Local Phone Number 678-1198
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Class A Ordinary Shares, $.0001 par value per share  
Title of 12(b) Security None
Trading Symbol N/A
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 2 23 1 false 1 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://edocmed.net/role/Cover Cover Cover 1 false false All Reports Book All Reports [dq-60546-Security12bTitle-Security-Axes] In submission type 8-K, Security12bTitle should have values without axes if a single non-ADR member, otherwise in separate contexts by axis member, but not both, in contexts From2024-03-212024-03-21_custom_ClassOrdinaryShares.0001ParValuePerShareMember. form8-k.htm 239 [dq-60547-EntityTaxIdentificationNumber-Missing] Submission type 8-K should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. form8-k.htm adoc-20240321.xsd adoc-20240321_def.xml adoc-20240321_lab.xml adoc-20240321_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "ADOC", "nsuri": "http://edocmed.net/20240321", "dts": { "schema": { "local": [ "adoc-20240321.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "adoc-20240321_def.xml" ] }, "labelLink": { "local": [ "adoc-20240321_lab.xml" ] }, "presentationLink": { "local": [ "adoc-20240321_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 1, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 64, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://edocmed.net/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://edocmed.net/role/Cover" ], "auth_ref": [] }, "ADOC_ClassOrdinaryShares.0001ParValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://edocmed.net/20240321", "localname": "ClassOrdinaryShares.0001ParValuePerShareMember", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class A Ordinary Shares, $.0001 par value per share" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001493152-24-011793-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-011793-xbrl.zip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end XML 19 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001824884 2024-03-21 2024-03-21 0001824884 ADOC:ClassOrdinaryShares.0001ParValuePerShareMember 2024-03-21 2024-03-21 iso4217:USD shares iso4217:USD shares false --12-31 0001824884 8-K 2024-03-21 EDOC Acquisition Corp. E9 001-39689 7612 Main Street Fishers Suite 200 Victor NY 14564 (585) 678-1198 false false false false true false None N/A